Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
$77,845R37FY2023CANIH
Fred Hutchinson Cancer Center, Seattle WA
Investigators
Linked publications, trials & patents
Paper 39605726Paper 39161959Paper 39052387Paper 38077017Paper 35512219Paper 35058622Paper 34469736Paper 34373451Paper 34236315
Abstract
PROJECT SUMMARY/ABSTRACT Per the FOA, this section is not required. The research supplement proposal does not change the activities of the parent award.
View original record on NIH RePORTER →